The Role Of Data and Emergent Technologies In Managing Health

When the Human Body
is the Biggest Data Platform,
who will Capture Value?

What do industry stakeholders really want?
Page 3
As a patient:
As a provider:
As a payer:
As a policymaker:
As a biopharma or medtech:
How can I get the right, affordable treatment and support to be
healthy?
How can I deliver the most cost-effective treatment to achieve health
improvement?
How can I provide the most cost-effective health solutions to get the
maximum impact?
How can I have a transparent market with a balance of health
improvement vs. cost?
How can I get appropriately paid for providing the right treatment
solution?
Unlocking the power of data to improve health outcomes: five trends to watch (Follow us on Twitter: @JoTaylor6, @EY_LifeSciences)

Data-driven platforms will be the “routers” of a digital health backbone that delivers ‘shared’ value
to all stakeholders
Page 4
Customers
Payer
Physician/care provider
Policymaker
Patient/consumer
Payer
Policymaker
Patient/consumer
Payer
Policymaker
Patient/consumer
Payer
Policymaker
Patient/consumer
Forces
► R&D productivity
► Patent cliff
► Regulatory hurdles
4.0
Life sciences
3.0Health outcomes
Life sciences
2.0Diversified
portfolios
Life sciences
1.0Blockbuster products
Life sciences
Data-driven
platforms
► Payer consolidation
► Empowered patients
► Reimbursement
pressures
► Exponential tech –
sensors and AI
► Super consumers
► Focused business
models

Empowered stakeholders demand and drive technological advancements, which fuels this
data explosion
Page 5
Augmented reality
Connected
home
Genetic and “–omic”
technologies
Electronic health
record platforms
Social media
platforms
Diagnostics
and imaging
Robotic surgery
Sensors/wearables

The shift to digitalization and “datafication” is reshaping the Health Sciences and Wellness industry
in fundamental ways …
What’s now What’s next
Payers, consumers and new entrants have the power
Connected devices allow continuous disease management
Health ecosystem is static and well-defined
Value is captured by owning all the data
Drugs and medical devices are the highest value products
Super-consumers demand convenient, seamless care
New technologies allow “pre-disease” identification and
treatment
Data and algorithms are the highest value product
Value is captured by sharing the data with ecosystem
stakeholders
Health ecosystem is a dynamic network
Page 6 Unlocking the power of data to improve health outcomes: five trends to watch (Follow us on Twitter: @JoTaylor6, @EY_LifeSciences)

… with implications for where, how and who will drive health care — anytime anywhere
Page 7
Point of care
Hospitals
Home
Care delivered in the
home via telehealth and
IoT-enabled devices
Data ownership
Institutions
Consumers
Consumers own their
health data, accessing
it through secure
platforms
Reference point
Population
Individual
Treatment is
personalized to drive
adherence to care
plans
Physician’s role
Authority
Guide
Physicians guide
individuals, who use
data to take control of
their health
Data analysis
Separated
Integrated
Big data give insights to
consumers and care
teams to drive behavior
change
Today
Future

Based on these transformative forces and the growing power of data, there are five key trends all
stakeholders need to consider
Page 8
Data will be better connected, combined and shared across the health
ecosystem1
Nanomedicine, sensors and artificial intelligence will be recognized as the
nervous system driving innovation
The patient-consumer will demand increasing power and influence over
other stakeholders
A “digital backbone” will emerge across the industry … but who will own it?
Therapeutic focus and the adoption of specialized business models will
position companies to outperform
2
3
4
5

Today, traditional and new data resources remain siloed — within and across organizations
Page 9
Consumer/
technology/
financial
companies
Biopharma
and medtech
companies
Pharmacies
Physicians
and
hospitals
Consumers
and
caregivers
Governments
and
NGOs
Laboratories
Payers
• Health record data
• Consumer-generated
sensor/device data
• DTC genetic tests
• Preclinical research
• Clinical trial data
• Biomarker analyses
• Post-market analyses
• Cost data
• Demographic data
• Biomedical data
• Environmental data
• Claims, cost data
• Actuarial analyses
• Social media commentary
• Sensor data
• Quantified self/fitness tracking
• Pricing for goods and services
• Consumer behavior data (preferences, purchasing
patterns)
• Socioeconomic profiling data
• Product sales, script volumes
• Medication adherence
• Consumer purchasing data, retail health
services data
• Biomarker and genetic assessment
• Diagnostic results
1

No company has all the data it needs to improve health outcomes; they must partner to co-
create future value
Page 10
1
Future
value
Innovation
Outcomes x Personalization
For people
For physicians
For payers
For policymakers
Participatory
Precise Predictive
Proactive
Data streams Traditional and non-
traditional partners
Platforms of care
(Connect + Combine + Share)
=
FV=ID
Data

Nanomedicine, sensors and artificial intelligence will be recognized as the nervous
system driving innovation
Unlocking the power of data to improve health outcomes: five trends to watchPage 11
2
► Virtual assistants
► Smart furniture/appliances
► Autonomous vehicles
► Home infrastructure
► Monitoring
► Diagnosis and management
► Prevention
► Consumers
► Caregivers
► Fitness trackers
► Connected clothing
► Band-aids and patches
► Connected monitors/ devices
► Monitoring
► Diagnosis and management
► Consumers
► Caregivers
► Providers/payers
► Sensor-embedded pills
► Smart dust
► Bioelectronic implants
► Nanobots
► Cyborg cells
► Management
► Cellular repair
► Prevention
► Providers
► Payers
Next:
ExamplesUseCustomer
Robust medical grade data, clinical trialsBig data and analytics
Environmental and
home sensors
Personal wearable
sensors and patches
Ingestible and
embedded sensors Now:
Beyond:
Time to market

Sensors are transforming the speed and scope of data capture … Artificial Intelligence will
make that data actionable at scale
Page 12
2
Chronic disease management
Clinical trials
Personalized coaching
Clinical decision support
Behavioral intervention
Remote monitoring/ telehealth
Drug development
Disease diagnosis

A “digital backbone” will emerge across the industry … but who will own it?
Page 13
3
Laboratories
Physicians/hospitals
Biopharmas/medtechs
Government/NGOs
Pharmacies
Consumer-focused companies
(retail, financial, tech, services)
Consumers/caregivers
Payers

Data-driven platforms will become the “routers” of the digital backbone
Page 14
3
Platform: an interface that enables a seamless trading exchange
Convenient to
use
Focused on user
experience
Connects
highly
disparate
groups
Simplifies access to
the best products and
services
► Increased
efficiency
► Better consumer
experience
► Personalized care
► Increased access
► Improved
health
outcomes
Benefits:
Platform interfaces

The growing empowerment of the patient-consumer dominates an industry-wide
power shift
Page 15
4
Biopharma and medtech
Patient-consumers
Payers
Policymakers
Technology
Employers
Retailers
Traditional power Future power Power shift

How is value
created?
High dollar
value capture
Low dollar value
capture
Who demands value?
Wealthy individuals
Highly innovative
products and
services
Institutional health care
systems
Efficient operations
and supply chain
Mass market
consumers
Customer understanding
and relationships
Breakthrough
innovator
Efficient
producer
Disease
manager
Lifestyle
manager
Source: EY. Concept developed from an
initial idea first profiled by Prof. Brian D.
Smith in his book, The Future of Pharma,
published by Gower Publishing in 2011.
Therapeutic focus and the adoption of specialized business models will position companies
to outperform5

Each of the four business models requires different data capabilities to optimize value
Page 17
5
Key data imperatives
Data to validate
product effectiveness
Data to personalize
and optimize patient
outcomes
Data to customize
end-user interactions
End goal
Data to manage
operational margins
Lifestyle
manager
Deliver commodity
products better
Efficient
producer
Deliver consumer-centric
services
Businessmodels
Break-
through
innovator
Disease
manager
Deliver best-in-class
efficacy
Deliver end-to-end
continuum of care

Based on these transformative forces and the growing power of data, there are five key trends all
stakeholders need to consider
Page 18
Data shared across the health ecosystem1
AI will make data actionable at scale2
Who will own the “Digital Backbone” and capture
value?3
The patient-consumer will become the most
influential stakeholder4
Specialized business models will be the future of
Life Science5

► Every biopharma company needs to be a data company not just a product company.
► Reorientation is needed around the “consumer experience.”
► Future value will come from the ability to deliver outcomes from innovation.
► Outcomes will require innovations that use data and personalization.
► To maximize the value of data, collaborative platforms are required that link to ubiquitous
backbone.
► Delivering differentiated outcomes requires an ecosystem rather than point solutions.
► Companies must align their data strategy to their business model to create maximum
value.
Turning data into value
Re-energizing your strategy

Thank you

EY | Assurance | Tax | Transactions | Advisory
About EY
EY is a global leader in assurance, tax, transaction and advisory services. The
insights and quality services we deliver help build trust and confidence in the capital
markets and in economies the world over. We develop outstanding leaders who team
to deliver on our promises to all of our stakeholders. In so doing, we play a critical role
in building a better working world for our people, for our clients and for our
communities.
EY refers to the global organization, and may refer to one or more, of the member
firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst
& Young Global Limited, a UK company limited by guarantee, does not provide
services to clients. Information about how EY collects and uses personal data and a
description of the rights individuals have under data protection legislation is available
via ey.com/privacy. For more information about our organization, please visit ey.com.
About EY Health Sciences and Wellness
The rise of the empowered consumer, coupled with technology advancements and the
emergence of digitally focused entrants, is changing every aspect of health and care
delivery. To retain relevancy in today’s digitally focused, data-infused ecosystem, all
participants in health care today must rethink their business practices, including
capital strategy, partnering and the creation of patient-centric operating models.
The EY Health Sciences and Wellness architecture brings together a worldwide
network of more than 20,000 professionals to build data-centric approaches to
customer engagement and improved outcomes. We help our clients deliver on their
strategic goals; design optimized operating models; and form the right partnerships so
they may thrive today and succeed in the health systems of tomorrow. We work
across the ecosystem to understand the implications of today’s trends, proactively
finding solutions to business issues and to seize the upside of disruption in this
transformative age.
© 2019 EYGM Limited.
All Rights Reserved.
EYG no. 002126-19Gbl
1902-3068211 US CSG
ED None
ey.com/lifesciences

The Role Of Data and Emergent Technologies In Managing Health

Recommandé

Recommandé

Contenu connexe

Tendances

Tendances (20)

Similaire à The Role Of Data and Emergent Technologies In Managing Health

Similaire à The Role Of Data and Emergent Technologies In Managing Health (20)

Plus de IFAH

Plus de IFAH (20)

Dernier

Dernier (20)

The Role Of Data and Emergent Technologies In Managing Health